Melatonin agonists in primary insomnia and depression-associated insomnia : are they superior to sedative-hypnotics?
Abstract: Current pharmacological treatment of insomnia involves the use of sedative-hypnotic benzodiazepine and non-benzodiazepine drugs. Although benzodiazepines improve sleep, their multiple adverse effects hamper their application. Adverse effects include impairment of memory and cognitive funct...
Guardado en:
| Autores principales: | Srinivasan, Venkataramanujan, Brzezinski, Amnon, Pandi Perumal, Seithikurippu R., Spence, David Warren, Cardinali, Daniel Pedro, Brown, Gregory M. |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés Inglés |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/1609 |
| Aporte de: |
Ejemplares similares
-
Melatonin and its analogs in insomnia and depression
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019) -
Some implications of melatonin use in chronopharmacology of insomnia
por: Golombek, Diego A., et al.
Publicado: (2019) -
Melatonin agonists for treatment of sleep and depressive disorders
por: Srinivasan, Venkataramanujan, et al.
Publicado: (2019) -
New developments in the treatment of primary insomnia in elderly patients : focus on prolonged-release melatonin
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019) -
Pharmacotherapy of insomnia with ramelteon : safety, efficacy and clinical applications
por: Pandi Perumal, Seithikurippu R., et al.
Publicado: (2019)